Checkpoint inhibitors can only amplify an antitumor immune response that already exists, which is why immunologically “cold” ...
Generative AI is rapidly entering oncology, from literature review and medical writing to trial prescreening and clinical ...
Long-term exposure to cigarette smoke reshapes distinct populations of lung stem cells, and the reshaped cell state deciding ...
Engineered bacteria are moving from curiosity to a funded platform. A five-year, $13.1 million National Institutes of Health ...
Children, Families, and the 2026 Revised Blood Guidance for Jehovah's Witnesses - An Update for Pediatric Hematology and ...
A Bullish Biotech Funding Market and a Higher Bar for Companies Seeking Capital - Importance of milestone-based development ...
Breast Cancer Awareness Month has evolved far beyond a public-health campaign. Over four decades, patient advocacy, philanthropy, data collection, molecular science, and increasingly sophisticated ...
Neil Kramer, MD, is a rheumatologist at Atlantic Health Overlook Medical Center, Physician Researcher, Atlantic Health ...
Calvin Chao, MD, MBA, Vice President of Medical Science at Artera, is a medical executive with expertise spanning oncology, ...
CAR-T therapy, which transformed the treatment of B-cell blood cancers, is now being tested as a way to reset the immune system in severe ...
Breast cancer prevention remains an important opportunity to move care earlier in the disease continuum, particularly by addressing measurable risk factors such as mammographic breast density (MBD).
Cata-Kor NMN and Liposomal NAD⁺ are now available at Target stores and Target.com nationwide in retail-exclusive 25-serving packs — the brand's first move from e-commerce leader to national ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results